Cyril Prieur

830 total citations
20 papers, 223 citations indexed

About

Cyril Prieur is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Cyril Prieur has authored 20 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Cyril Prieur's work include Acute Myocardial Infarction Research (6 papers), Signaling Pathways in Disease (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Cyril Prieur is often cited by papers focused on Acute Myocardial Infarction Research (6 papers), Signaling Pathways in Disease (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Cyril Prieur collaborates with scholars based in France, United States and Switzerland. Cyril Prieur's co-authors include Jacques Robin, J. Neidecker, Mattéo Pozzi, Jean‐François Obadia, Xavier Armoiry, Eric Bonnefoy‐Cudraz, Nathan Mewton, Thomas Bochaton, J F Obadia and Daniel Grinberg and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Heart Journal.

In The Last Decade

Cyril Prieur

17 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cyril Prieur France 7 94 93 72 65 30 20 223
László Göbölös United Kingdom 8 36 0.4× 70 0.8× 110 1.5× 75 1.2× 9 0.3× 31 220
Sofia Ortuno France 5 87 0.9× 98 1.1× 87 1.2× 68 1.0× 8 0.3× 13 197
Julien Goutay France 9 35 0.4× 56 0.6× 44 0.6× 26 0.4× 19 0.6× 11 189
Jacqueline Szmuszkovicz United States 8 36 0.4× 28 0.3× 132 1.8× 58 0.9× 8 0.3× 23 218
Hannah Schaubroeck Belgium 9 57 0.6× 47 0.5× 51 0.7× 52 0.8× 7 0.2× 25 198
Anaïs Curtiaud France 10 26 0.3× 33 0.4× 42 0.6× 34 0.5× 18 0.6× 20 238
Jeremy W. Vandiver United States 8 25 0.3× 46 0.5× 115 1.6× 150 2.3× 8 0.3× 13 313
Yuhong Mi China 7 23 0.2× 20 0.2× 40 0.6× 70 1.1× 28 0.9× 13 183
V. Tursi Italy 13 31 0.3× 62 0.7× 192 2.7× 133 2.0× 25 0.8× 35 360
Elena Corrada Italy 12 44 0.5× 55 0.6× 121 1.7× 223 3.4× 5 0.2× 41 340

Countries citing papers authored by Cyril Prieur

Since Specialization
Citations

This map shows the geographic impact of Cyril Prieur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Prieur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Prieur more than expected).

Fields of papers citing papers by Cyril Prieur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Prieur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Prieur. The network helps show where Cyril Prieur may publish in the future.

Co-authorship network of co-authors of Cyril Prieur

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Prieur. A scholar is included among the top collaborators of Cyril Prieur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Prieur. Cyril Prieur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paccalet, Alexandre, Bruno Pillot, Lionel Augeul, et al.. (2024). Deleterious Anti-Inflammatory Macrophage Recruitment in Early Post-Infarction Phase. JACC Basic to Translational Science. 9(5). 593–604. 4 indexed citations
2.
Si‐Mohamed, Salim, et al.. (2024). Mechanical Thrombectomy in a Single-Lung Transplant Recipient: A Salvage Case. American Journal of Respiratory and Critical Care Medicine. 210(7). e1–e2. 1 indexed citations
3.
Hayek, Ahmad, Cyril Prieur, Eric Bonnefoy‐Cudraz, et al.. (2024). Kinetics and Prognosis Value of CCL5/RANTES at the Acute Phase of ST‐Segment–Elevation Myocardial Infarction. Journal of the American Heart Association. 13(19). e033110–e033110.
4.
Hayek, Ahmad, Cyril Prieur, Nicolas Dürrleman, et al.. (2024). Clinical considerations and challenges in TAV-in-TAV procedures. Frontiers in Cardiovascular Medicine. 11. 1334871–1334871. 3 indexed citations
5.
Hayek, Ahmad, Alexandre Paccalet, Cyril Prieur, et al.. (2024). Osteopontin is a relevant prognostic biomarker in STEMI patients. Archives of cardiovascular diseases. 117(6-7). S180–S180.
6.
Zeller, Marianne, Nicolas Danchin, Yves Cottin, et al.. (2023). Standard modifiable risk factors and mortality in patients with ST-segment elevation myocardial infarction: Findings from the FRENCHIE cohort. Archives of cardiovascular diseases. 117(1). S3–S4. 1 indexed citations
7.
Boccalini, Sara, et al.. (2023). Comprehensive Imaging of Coronary Stent Using Ultra-High Resolution Spectral Photon Counting CT. JACC: Cardiovascular Interventions. 16(19). 2466–2468. 5 indexed citations
8.
Hayek, Ahmad, Mattéo Pozzi, Daniel Grinberg, et al.. (2022). Ventricular septal rupture: insights into an old disease. Heart and Vessels. 37(8). 1305–1315. 1 indexed citations
9.
Mewton, Nathan, Ahmad Hayek, Camille Amaz, et al.. (2022). Predictive inflammatory biomarkers for left ventricular thrombus in acute myocardial infarction. Archives of Cardiovascular Diseases Supplements. 14(2). 173–174.
10.
Prieur, Cyril, et al.. (2022). Safety of SARS-CoV-2 vaccination in people with a history of acute myocarditis. European Heart Journal Acute Cardiovascular Care. 11(Supplement_1). 2 indexed citations
11.
Bochaton, Thomas, Alexandre Paccalet, François Dérimay, et al.. (2021). Association of myocardial hemorrhage and persistent microvascular obstruction with circulating inflammatory biomarkers in STEMI patients. PLoS ONE. 16(1). e0245684–e0245684. 17 indexed citations
12.
Paccalet, Alexandre, Claire Crola Da Silva, Laura Mechtouff, et al.. (2021). Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After ST-Segment Elevation Myocardial Infarction. Frontiers in Pharmacology. 12. 656928–656928. 20 indexed citations
13.
Hayek, Ahmad, Alexandre Paccalet, Laura Mechtouff, et al.. (2021). Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients. Immunity Inflammation and Disease. 9(2). 493–501. 13 indexed citations
14.
15.
Huet, Fabien, Cyril Prieur, Guillaume Schurtz, et al.. (2020). One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic. Archives of cardiovascular diseases. 113(5). 303–307. 40 indexed citations
16.
Paccalet, Alexandre, Claire Crola Da Silva, Camille Amaz, et al.. (2020). IL-10 / IL-6 serum ratio as a prognosis marker of STEMI. European Heart Journal. 41(Supplement_2). 1 indexed citations
17.
Prieur, Cyril, et al.. (2017). Percutaneous Management of Mitral Perforation During Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 10(16). 1710–1711. 4 indexed citations
18.
19.
Bochaton, Thomas, Nathan Mewton, Fabien Lavocat, et al.. (2017). Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction. PLoS ONE. 12(11). e0188202–e0188202. 15 indexed citations
20.
Pozzi, Mattéo, Xavier Armoiry, J. Neidecker, et al.. (2015). Extracorporeal life support for refractory out-of-hospital cardiac arrest: Should we still fight for? A single-centre, 5-year experience. International Journal of Cardiology. 204. 70–76. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by László Göbölös Breakdown of academic impact, for papers by Sofia Ortuno Breakdown of academic impact, for papers by Julien Goutay Breakdown of academic impact, for papers by Jacqueline Szmuszkovicz Breakdown of academic impact, for papers by Hannah Schaubroeck Breakdown of academic impact, for papers by Anaïs Curtiaud Breakdown of academic impact, for papers by Jeremy W. Vandiver Breakdown of academic impact, for papers by Yuhong Mi Breakdown of academic impact, for papers by V. Tursi Breakdown of academic impact, for papers by Elena Corrada
Rankless by CCL
2026